← Back to headlines
Merck and Kelun Lung Cancer Drug Shows Superiority
A combination therapy for lung cancer developed by Merck and Kelun has demonstrated better results than Keytruda in a late-stage clinical trial.
22 May, 12:12 — 22 May, 12:12
Sources
Showing 1 of 1 sources
